Ipca Laboratories today said its net profit declined by 17.07% to Rs 77.96 crore for the second quarter ended September 30, 2011, over the same period previous fiscal.
The company had posted a net profit of Rs 94.01 crore for the same period last financial year, Ipca Laboratories said in a filing to the BSE.
However, net sales of the firm rose to Rs 618.02 crore for the second quarter, as against Rs 514.29 crore for the same period last fiscal.
The company's board, which met today, also approved an interim dividend of 50% (Re 1 per share) for the financial year 2011-12.
Shares of Ipca Laboratories were trading at Rs 248.40 on the BSE in afternoon trade, up 3.41% from previous close.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app